FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US, Authority Hl7

16,284 resources

Type: Text:

By Version

 

Start Prev Rows 10200 - 10400 Next

PackageVersionIdentityName/TitleStatusFMMWGDate
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.496Pembrolizumabactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.497Dostarlimabactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.498Selpercatinibactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.499Everolimusactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.500Trastuzumab_deruxtecanactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.501Test 23active2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.502All Metastatic sites Endometrial SNOMEDactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.503All Metastatic sites Endometrial ICD9active2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.504All Metastatic sites Endometrial ICD10active2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.505All Metastatic sites Endometrialactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.506Create CRC_Cancer_T4a_Stageactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.507Create CRC_Cancer_T4b_Stageactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.508High Emetogenic Risk Chemotherapyactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.510InactiveFollowupactive2025-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.53MMR Gene Testingactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.54MSI Highactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.55MSI Highactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.6Orserduactive2023-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.61Stage IIB or lower and limitedactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.62Stage III or higheractive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.63Stage III or higheractive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.64Stage III or higheractive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.65Staging Unknownactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.66Staging Unknownactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.67Staging Unknownactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.68Jemperliactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.69Uterine Sarcomaactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.7Her2 Test For Orserduactive2023-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.70Tumor Histologyactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.71Platinum based therapyactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.72Prior Therapies for Tucatinibactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.73Tucatinibactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.74Colorectal Cancer ICD10active2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.75Colorectal Cancer ICD9active2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.76Colorectal Cancer ICD9 and ICD10active2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.78Advanced or Unresectable Colorectal Cancer Stagingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.790 to IIIB Colorectal Cancer Stagingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.80Colorectal Cancer M1 Stageactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.81RAS Genesactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.82RAS Gene Interpretation Negative LOINCactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.83RAS Gene Interpretation Negative SNOMEDactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.84RAS Gene Interpretation Negative NCMactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.85RAS Gene Negativeactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.86RAS Gene Interpretation Positive SNOMEDactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.87RAS Gene Interpretation Positive LOINCactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.88RAS Gene Positiveactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.89Her2 Testingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.90Patient Reasonactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.91MSI High NCIactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.92MSI Low SNOMEDactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.93MSI Low LOINCactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.94MSI Low NCIactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.95MSI Lowactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.96MMR Deficient NCIactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.97MMR Proficient SNOMEDactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.98MMR Proficient LOINCactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.99MMR Proficient NCIactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1262.3ICD9 Codes for HIV Diagnosisactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.1Inpatient Pneumonia Diagnosisactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.11Chest Imaging for Pneumonia, HCPCSactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.12Chest Imaging for Pneumonia Grouping Definitionactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.18ICD9 Abnormal Finding on Chest Imagingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.19ICD10 Abnormal Finding on Chest Imagingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.2ICD9 Pneumonia Definitionactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.20SNOMEDCT Abnormal Finding on Chest Imagingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.21Abnormal Finding on Chest Imagingactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.22SNOMEDCT Pneumonia Definitionactive2023-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.23CAP Concurrent Infectionsactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.24CAP Pneumonia Diagnosticactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.25Antibiotic Usage for CAP Diagnosisactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.27Legionella Presence by Urine Antigen or DNAactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.29Broad Spectrum Antibiotics for MDROactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.3ICD10 Pneumonia Definitionactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.32CPT Transplants, Stem Cell and Solidactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.33HCPCS Transplant, Stem Cell and Solidactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.34ICD10CM Transplant, Stem Cell and Solidactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.35ICD10PCS Transplant, Stem Cell and Solidactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.37SNOMEDCT Transplant, Stem Cell and Solidactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.38Transplant, Stem Cell and Solidactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.39Antibiotic Usage for CAP Durationactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.40CAP Sepsis Diagnosticactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.41CAP Respiratory Failure Diagnosticactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.42MRSA Organism or Substance in Lab Resultsactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.8Systemic Antimicrobialsactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.9Chest Imaging for Pneumonia, CPTactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.1Problem Typeactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.10Information Source for Medication Adherence HSLOCactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.11Information Source for Medication Adherenceactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.14Unknown and Asked but Unknown (DAR)active2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.15Yes or No SCTactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.16Answer Set with Yes No and Unknownsactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.17Common LOINC Lab Codesactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.18Radiology Procedures (LOINC)active2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.21Universal Common LOINC Lab Ordersactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.22Route of Administration of Therapeutic Agentsactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.23Encounter Typeactive2025-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.27Social History Type (LOINC)active2025-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.28Social History Typeactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.3Smoking status comprehensiveactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.4Smoking Status Type LOINCactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.5Smoking Status Pack Years SCTactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.6Smoking Status Typeactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.7Information Source for Medication Adherence HL7 Role Codeactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.8Information Source for Medication Adherence ParticpationFunctionactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.9Information Source for Medication Adherence SCTactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.1Malnutritionactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.10Fractureactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.11Transplant Diagnosesactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.13Transplant Diagnoses ICD10CMactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.14Transplant Diagnoses SNOMED CTactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.15Respiratory Proceduresactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.3Diabetesactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.4Diabetesactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.5Diabetesactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.6Immobilityactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.7Smoking statusactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.8Obesityactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.9Hormone Therapyactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.1Drug Intervention Not Indicated/Contraindicatedactive2024-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.10Endotracheal Intubationactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.2Procedure Not Indicated/Contraindicatedactive2024-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.9Mechanical Circulatory Assist Deviceactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1289.1RXNormSBD0305active2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1289.2RXNormSCD0305active2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1290.4Sequential Organ Failure Assessment SOFAactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.10612Unknown Nullactive2019-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.19601x_ServiceEventPerformeractive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20549Criticality Observationactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.15.2.5.1Initial Case Report Trigger Code Result Statusactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.15.2.5.12Therapeutic Response to Medicationactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.2Codes for MDRO and CDI Summary Data LTCFactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.3NHSNPrimaryResidentServiceTypeactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.4Codes for Denominators for Long Term Care Locations LTCFactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.5Codes for Prevention Process Measures LTCFactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.9.1NHSNReportNoEventsMDROLTCFactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.10Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Dataactive2019-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.11Codes for Hemovigilance (HV) Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.12Codes for Intensive Care Unit (ICU) Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.13Codes for Neonatal Intensive Care Unit (NICU) Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.15Codes for Prevention Process and Outcome Measures (POM) Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.16Codes for Specialty Care Area (SCA) Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.17Codes for Vascular Access Type (Dialysis) Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.18NHSNReportNoEventsICUactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.19NHSNReportNoEventsNICUactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.20NHSNReportNoEventsSCAactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.21NHSNReportNoEventsMDROactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.22NHSNReportNoEventsDialysisactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.24NHSNVascularSpecimenCollectionSiteactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.29NHSNSSIDetectionMethodactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.3NHSNLastLocationEncounterTypeCodeactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.30NHSNLOS/MENDischargeDispositionactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.31NHSNSSIDetectionMethodTypeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.32Codes for Outpatient Procedure Component Same Day Outcome Measures Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.33NHSNReportNoEventsOPCSameDayOutcomeMeasuresactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.34NHSNOPCProcedureCategoryCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.35NHSNReportNoEventsARactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.4NHSNDrugSusceptibilityTestMethodactive2020-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.40NHSN COVID19 Case Classificationactive2021-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.5NHSN Pathogen Reduced Apheresis Platelet Usageactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.50NHSNGenotypicTestInterpretationactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.6HealthcarePersonnelTypeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.7NHSNInfluenzaVaccinationSettingactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.8Codes for Antimicrobial Resistance Option (ARO) Summary Dataactive2020-11
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.9Codes for Antimicrobial Usage, Pharmacy (AUP) Summary Dataactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.12.1Personal And Legal Relationship Role Typeactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.21AgePQ_UCUMactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.32DIRDocumentTypeCodesactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.47ADL Result Typeactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.49Residence and Accommodation Typeactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.50Sensory Status Problem Typeactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.51Healthcare Agent Qualifieractive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.52Encounter SCTactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.56Referral Typesactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.62Related Document (append/replace)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.66Patient Referral Act moodCodeactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.68Note Typesactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.69.4Advance Healthcare Directive Categories LOINCactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.1NHSNEncounterTypeCodeactive2019-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.10NHSNASAClassCodeactive2019-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.11NHSNSpinalFusionLevelCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.12NHSNOccasionOfDetectionCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.13NHSNDrugSusceptibilityFindingCodeactive2020-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.15NHSNDrugSusceptibilityTestsCodeactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.16NHSNPathogenCodeactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.17NHSNProcedureCategoryCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.19NHSNHealthcareServiceLocationCodeactive2019-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.2NHSNSpinalFusionApproachCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.20NHSNInfectionTypeCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.3NHSNHipReplacementCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.4NHSNKneeReplacementCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.6NHSNInfectionRiskFactorsCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.7NHSNBloodStreamInfectionEvidenceTypeCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.9NHSNWoundClassCodeactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.17.4077.2.1017Closed Head and Facial Traumaactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.17.4077.2.1018Closed Head and Facial Traumaactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.134Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatmentactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.136Perforation of Uterusactive2024-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.137Uterine Windowactive2021-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.138Uterine Ruptureactive2024-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.200Anticoagulant Therapyactive2025-02